Machine Learning Based Models for High-Throughput Classification of Human Pregnane X Receptor Activators

Yiyuan Gou,Lilai Shen,Shixuan Cui,Meiling Huang,Yiqu Wu,Penghan Li,Shulin Zhuang

DOI: https://doi.org/10.1039/d2va00182a

2022-01-01

Environmental Science Advances

Abstract:A machine learning-based model was developed for classifying PXR activators with high generalization capability and broad applicability domain.

What problem does this paper attempt to address?

In silico prediction of pregnane X receptor activators by machine learning approaches.

C. Y. Ung,H. Li,C. W. Yap,Y. Z. Chen

DOI: https://doi.org/10.1124/mol.106.027623

2007-01-01

Molecular Pharmacology

Abstract:Pregnane X receptor (PXR) regulates drug metabolism and is involved in drug-drug interactions. Prediction of PXR activators is important for evaluating drug metabolism and toxicity. Computational pharmacophore and quantitative structure-activity relationship models have been developed for predicting PXR activators. Because of the structural diversity of PXR activators, more efforts are needed for exploring methods applicable to a broader spectrum of compounds. We explored three machine learning methods (MLMs) for predicting PXR activators, which were trained and tested by using significantly higher number of compounds, 128 PXR activators (98 human) and 77 PXR nonactivators, than those of previous studies. The recursive feature-selection method was used to select molecular descriptors relevant to PXR activator prediction, which are consistent with conclusions from other computational and structural studies. In a 10-fold cross-validation test, our MLM systems correctly predicted 81.2 to 84.0% of PXR activators, 80.8 to 85.0% of hPXR activators, 61.2 to 70.3% of PXR nonactivators, and 67.7 to 73.6% of hPXR nonactivators. Our systems also correctly predicted 73.3 to 86.7% of 15 newly published hPXR activators. MLMs seem to be useful for predicting PXR activators and for providing clues to physicochemical features of PXR activation.
In silico identification of human pregnane X receptor activators from molecular descriptors by machine learning approaches

Hanbing Rao,Yanying Wang,Xianyin Zeng,Xianxiang Wang,Yong Liu,Jiajian Yin,Hua He,Feng Zhu,Zerong Li

DOI: https://doi.org/10.1016/j.chemolab.2012.05.012

IF: 4.175

2012-01-01

Chemometrics and Intelligent Laboratory Systems

Abstract:In the current study, computational models for hPXR activators and hPXR non-activators were developed using support vector machine (SVM), k-nearest neighbor (k-NN), and artificial neural networks (ANN) algorithms. 73 molecular descriptors used for hPXR activator and hPXR non-activator prediction were selected from a pool of 548 descriptors by using a multi-step hybrid feature selection method combining Fischer's score and Monte Carlo simulated annealing method. The y-scrambling method was used to test if there is a chance correlation in the developed SVM model. In the meantime, five-fold cross validation of these machine learning methods results in the prediction accuracies of 87.2–92.5% for hPXR activators and 73.8–87.8% for hPXR non-activators, and the prediction accuracies for external test set are 93.8–95.8% for hPXR activators and 86.7–92.8% for hPXR non-activators. Our study suggested that the tested machine learning methods are potentially useful for hPXR activators identification.
Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique.

Huali Shi,Sheng Tian,Youyong Li,Dan Li,Huidong Yu,Xuechu Zhen,Tingjun Hou

DOI: https://doi.org/10.1021/tx500389q

2015-01-01

Chemical Research in Toxicology

Abstract:The activation of pregnane X receptor (PXR), a member of the nuclear receptor (NR) superfamily, can mediate potential drugdrug interactions, and therefore, prediction of PXR activation is of great importance for evaluating drug metabolism and toxicity. In this study, based on 532 structurally diverse compounds, we present a comprehensive analysis with the aim to build accurate classification models for distinguishing PXR activators from nonactivators by using a naive Bayesian classification technique. First, the distributions of eight important molecular physicochemical properties of PXR activators versus nonactivators were compared, illustrating that the hydrophobicity-related molecular descriptors (AlogP and log D) show slightly better capability to discriminate PXR activators from nonactivators than the others. Then, based on molecular physicochemical properties, VolSurf descriptors, and molecular fingerprints, naive Bayesian classifiers were developed to separate PXR activators from nonactivators. The results demonstrate that the introduction of molecular fingerprints is quite essential to enhance the prediction accuracy of the classifiers. The best Bayesian classifier based on the 21 physicochemical properties, VolSurf descriptors, and LCFC_10 fingerprints descriptors yields a prediction accuracy of 92.7% for the training set based on leave-one-out (LOO) cross-validation and of 85.2% for the test set. Moreover, by exploring the important structural fragments derived from the best Bayesian classifier, we observed that flexibility is an important structural pattern for PXR activation. In addition, chemical compounds containing more halogen atoms, unsaturated alkanes chains relevant to pi-pi stacking, and fewer nitrogen atoms tend to be PXR activators. We believe that the naive Bayesian classifier can be used as a reliable virtual screening tool to predict PXR activation in the drug design and discovery pipeline.
Predicting the Androgenicity of Structurally Diverse Compounds from Molecular Structure Using Different Classifiers

Li Ji,Xiaodong Wang,Liang Qin,Si Luo,Liansheng Wang

DOI: https://doi.org/10.1002/qsar.200860090

2009-01-01

QSAR & Combinatorial Science

Abstract:Many environmental and industrial chemicals are reported to have androgenic or antiandrogenic activities. These androgenic chemicals may act as hormones and have the potential to disrupt the endocrine systems of wildlife and humans. In this study, the probabilistic neural network (PNN), support vector machine (SVM), and learning vector quantization (LVQ), three types of machine learning, were used to develop binary classification models to predict androgenicity directly from the organic compounds' molecular structures which were represented by only eleven numerical descriptors. The PNN model acquired the best overall classification rate of 86.67% for prediction data set, with Matthews Correlation Coefficient of 0.64, and the LVQ model gave the lowest false negative rate of 0.00%, which will tend to give relatively high priority during toxicology evaluation. In addition, a consensus model was produced that integrated all three of the basic model types. Compared with the individual models, this consensus model correctly predicted the androgenicity of 86.67% of the prediction set compounds, with false negative rate of 0.00% and the highest Matthews Correlation Coefficient of 0.65. The obtained results indicate that the proposed classification models could provide a feasible and practical tool for the rapid screening of potential androgens.
Identification and Validation of Novel Human Pregnane X Receptor Activators among Prescribed Drugs Via Ligand-Based Virtual Screening

Yongmei Pan,Linhao Li,Gregory Kim,Sean Ekins,Hongbing Wang,Peter W. Swaan

DOI: https://doi.org/10.1124/dmd.110.035808

2010-01-01

Abstract:Human pregnane X receptor (hPXR) plays a key role in regulating metabolism and clearance of endogenous and exogenous substances. Identification of novel hPXR activators among commercial drugs may aid in avoiding drug-drug interactions during coadministration. We applied ligand-based computational approaches for virtual screening of a commonly prescribed drug database (SCUT). Bayesian classification models were generated with a training set comprising 177 compounds using Fingerprints and 117 structural descriptors. A cell-based luciferase reporter assay was used for evaluation of chemical-mediated hPXR activation in HepG2 cells. All compounds were tested at 10 μM concentration with rifampicin and dimethyl sulfoxide as positive and negative controls, respectively. The Bayesian models showed specificity and overall prediction accuracy up to 0.92 and 0.69 for test set compounds. Screening the SCUT database with this model retrieved 105 hits and 17 compounds from the top 25 hits were chosen for in vitro testing. The reporter assay confirmed that nine drugs, i.e., fluticasone, nimodipine, nisoldipine, beclomethasone, finasteride, flunisolide, megestrol, secobarbital, and aminoglutethimide, were previously unidentified hPXR activators. Thus, the present study demonstrates that novel hPXR activators can be efficiently identified among U.S. Food and Drug Administration-approved and commonly prescribed drugs, which should lead to detection and prevention of potential drug-drug interactions.
Predictive Models for Identifying the Binding Activity of Structurally Diverse Chemicals to Human Pregnane X Receptor.

Cen Yin,Xianhai Yang,Mengbi Wei,Huihui Liu

DOI: https://doi.org/10.1007/s11356-017-9690-1

IF: 5.8

2017-01-01

Environmental Science and Pollution Research

Abstract:Toxic chemicals entered into human body would undergo a series of metabolism, transport and excretion, and the key roles played in there processes were metabolizing enzymes, which was regulated by the pregnane X receptor (PXR). However, some chemicals in environment could activate or antagonize human pregnane X receptor, thereby leading to a disturbance of normal physiological systems. In this study, based on a larger number of 2724 structurally diverse chemicals, we developed qualitative classification models by the k-nearest neighbor method. Moreover, the logarithm of 20 and 50% effective concentrations (log EC 20 and log EC 50) was used to establish quantitative structure-activity relationship (QSAR) models. With the classification model, two descriptors were enough to establish acceptable models, with the sensitivity, specificity, and accuracy being larger than 0.7, highlighting a high classification performance of the models. With two QSAR models, the statistics parameters with the correlation coefficient (R 2) of 0.702–0.749 and the cross-validation and external validation coefficient (Q 2) of 0.643–0.712, this indicated that the models complied with the criteria proposed in previous studies, i.e., R 2 > 0.6, Q 2 > 0.5. The small root mean square error (RMSE) of 0.254–0.414 and the good consistency between observed and predicted values proved satisfactory goodness of fit, robustness, and predictive ability of the developed QSAR models. Additionally, the applicability domains were characterized by the Euclidean distance-based approach and Williams plot, and results indicated that the current models had a wide applicability domain, which especially included a few classes of environmental contaminant, those that were not included in the previous models.
Advances in Search for Pregnane X Receptor

余帮宁,周宏灏

DOI: https://doi.org/10.3969/j.issn.1001-6821.2005.01.016

2005-01-01

Abstract:The pregnane X receptor (PXR), which belongs to a subfamily of the nuclear receptor, is an important component of the body's adaptive defense mechanism against toxic substances. PXR is activated by a broad spectrum of lipophilic xenobiotics such as prescription drugs, herbs etc.. Recent studies reveal that PXR plays an important role in regulating the genes of drug metabolism enzymes and drug transports. PXR also plays a key role in controlling bile acids homeostasis, protecting body from toxic bile acids. Because various prescription drugs can activate PXR, an important class of clinical drug-drug interactions may occur when these prescription drugs administrated with other drugs. Assays that detect PXR activation can now be used to predict these drug-drug interactions and prevent it.
Quantitative Prediction of Human Pregnane X Receptor and Cytochrome P450 3A4 Mediated Drug-Drug Interaction in a Novel Multiple Humanized Mouse Line

Maki Hasegawa,Yury Kapelyukh,Harunobu Tahara,Jost Seibler,Anja Rode,Sylvia Krueger,Dongtao N. Lee,C. Roland Wolf,Nico Scheer

DOI: https://doi.org/10.1124/mol.111.071845

2011-05-31

Molecular Pharmacology

Abstract:Cytochrome P450 (P450) 3A4 is the predominant P450 enzyme expressed in human liver and intestine, and it is involved in the metabolism of approximately 50% of clinically used drugs. Because of the differences in the multiplicity of CYP3A genes and the poor correlation of substrate specificity of CYP3A proteins between species, the extrapolation of CYP3A-mediated metabolism of a drug from animals to man is difficult. This situation is further complicated by the fact that the predictability of the clinically common drug-drug interaction of pregnane X receptor (PXR)-mediated CYP3A4 induction by animal studies is limited as a result of marked species differences in the interaction of many drugs with this receptor. Here we describe a novel multiple humanized mouse line that combines a humanization for PXR, the closely related constitutive androstane receptor, and a replacement of the mouse Cyp3a cluster with a large human genomic region carrying CYP3A4 and CYP3A7. We provide evidence that this model shows a human-like CYP3A4 induction response to different PXR activators, that it allows the ranking of these activators according to their potency to induce CYP3A4 expression in the human liver, and that it provides an experimental approach to quantitatively predict PXR/CYP3A4-mediated drug-drug interactions in humans.

pharmacology & pharmacy
Identification of Hpxr Modulators Via Sar-Based Virtual Screening

Yongmei Pan,Linhao Li,Gregory Kim,Sean Ekins,Hongbing Wang,Peter Swaan

DOI: https://doi.org/10.1016/j.bpj.2010.12.1948

IF: 3.4

2011-01-01

Biophysical Journal

Abstract:Purpose. Human pregnane X receptor (hPXR) has a key role in regulating metabolism of endogenous and exogenous substances. Identification of novel hPXR activators among commercial drugs aids in avoiding drug-drug interactions with future co-administered drugs. Methods. Virtual screening with Structure-Activity Relationship (SAR) models has been applied for identification of novel hPXR activators. Ligand-based modeling was conducted with Discover Studio (DS) 2.1. Bayesian classification models were generated with a training set comprising 177 compound, and were validated with a test set with 145 compounds. The activities of commonly prescribed drugs from SCUT database were predicted with one of the Bayesian models. Cell-based luciferase reporter assay was used for evaluation of chemical-mediated hPXR activation. HepG2 cells were co-transfected with PXR expression vector and CYP2B6-luciferase reporter construct. 0.1% DMSO solution was used as vehicle control while rifampicin as the positive control. The binding mode between an experimental validated hPXR modulators and hPXR were studied by docking a ligand into hPXR binding domain (PDB ID: 1NRL) with programs FlexX and SurFlex. Results. The Bayesian models showed specificity and overall prediction accuracy up to 0.92 and 0.69 for test set compounds. One Bayesian model with specificity of 0.92 was selected to screen the SCUT database and retrieved 113 hits. 17 compounds were chosen for in vitro testing. The luciferase reporter assay confirmed that seven drugs, i.e., fluticasone, nimodipine, nisoldipine, beclomethasone, finasteride, flunisolide, and megestrol were previously unidentified potent or moderate hPXR activators, with 2.7 to 18.5- fold increase in luciferase activity compared to vehicle control. Conclusion. In this study, virtual screening based on SAR models successfully identified seven novel hPXR activators among FDA approved and commonly prescribed drugs. The same approach could be used for identification of activators or inhibitors of other protein targets.
Prediction of Farnesoid X Receptor Disruptors with Machine Learning Methods.

Yue Chen,Hongbin Yang,Zengrui Wu,Guixia Liu,Yun Tang,Weihua Li

DOI: https://doi.org/10.1021/acs.chemrestox.8b00162

2018-01-01

Chemical Research in Toxicology

Abstract:The farnesoid X receptor (FXR) emerges as a promising drug target involved in regulating various metabolic pathways, yet some xenobiotic compounds binding to FXR would be an important determinant to induce the receptor dysfunctions that lead to undesirable side effects. Thus, it is critical to identify potential xenobiotics that disrupt normal FXR functions. In this work, five machine learning methods coupled with eight molecular fingerprints and 20 molecular descriptors were used to develop classification models for prediction of FXR binders. The built models were evaluated using the test set and two external validation sets. The best model was obtained using a combination of molecular descriptors and fingerprints, which exhibited the AUC values of 0.83 and 0.92 for the test set and the first external validation set, respectively. The overall prediction accuracy for the second external validation set with the best model was over 85%. Furthermore, several representative privileged substructures that are essential for FXR binders, such as benzimidazole, indole, and stilbene moiety, were detected using information gain and substructure frequency analysis. The applicability domain analysis via the Euclidean distance-based approach demonstrated a marked impact on the improvement of prediction accuracy. Overall, our built models could be helpful to rapidly identify potential chemicals binding to FXR.
Rapid Screening of Chemicals with Placental Transfer Risk Using Interpretable Machine Learning

Xiaojia Chen,Jingzhi Yao,Yu Ma,Yuanyuan Fang,Wenxin Wang,Xiaojun Deng,Ling Tan,Yi-Jun Fan,Mingliang Fang

DOI: https://doi.org/10.1021/acs.estlett.4c00413

IF: 11.558

2024-01-01

Environmental Science & Technology Letters

Abstract:Assessing the placental transfer efficiency of toxic chemicals remains challenging. Here, a robust machine learning (ML) model was developed to predict the human fetal-maternal blood concentration ratio (F/M) at the exposomic level. By curating one of the largest F/M data sets, we evaluated a series of prediction models using a combination of 12 ML algorithms and four molecular fingerprints. The long short-term memory (LSTM) model with retraining optimization works as the best performer, displayed robust accuracy (R2 train = 0.91, R2 test = 0.68), and was subsequently applied to our previously developed risk-based Human Exposome and Metabolite Database (HExpMetDB). The fetal hazard quotient (FHQ) was assessed using the predicted F/M ratios, probabilistic exposure dose, and toxicity index. From the top 1000 prioritized chemicals via FHQs ranking, we randomly selected four candidates (triethyl phosphate, benzotriazole, oxybenzone, and dichlormid) to perform in vivo experiments. All four chemicals exhibited transplacental potential (F/M ratio >0.3) as new possible chemicals of concern, demonstrating the accuracy of the predictive model. The Shapley additive explanation (SHAP) method revealed the top 10 key structural fragments related to the transplacental transfer efficiency. We believe that the prediction model can serve as an effective tool to screen potential risk compounds of fetal exposure.
Establishment of hPXR Mediated Reporter Gene Model for UGT1A1 and Its Application

王君燕,余露山,曾苏

2012-01-01

Abstract:OBJECTIVE: To develop hPXR mediated reporter gene model for UGT1A1, and use it as an in vitro model for determination of induction activity toward UGT1A1 of various commonly used traditional Chinese medicines (TCMs) extracts. METHODS: The distal and proximal promoters of UGT1A1 were amplified from human genetic DNA, and were cloned into pGL3 vector as pGL3-PXRE plasmid, which was then cotransfected into HepG2 cells with hPXR expression plasmid to establish the reporter gene model. Then the model was applied to determine the induction activity toward UGT1 A1 of various commonly used TCMs extracts. RESULTS: The promoters of UGT1A1 were successfully cloned into pGL3 vector to form pGL3-PXRE recombinant plasmid, and the reporter gene model was successfully established. Nine kinds of TCMs extracts were investigated, and three were found to activate hPXR and therefore have the potential to induce UGT1A1. CONCLUSION: The model established is an effective method for determination of activators of hPXR and potential inducers of UGT1A1 in vitro. Copyright 2012 by the Chinese Pharmaceutical Association.
Machine Learned Classification of Ligand Intrinsic Activities at Human μ-Opioid Receptor

Myongin Oh,Maximilian Shen,Ruibin Liu,Lidiya Stavitskaya,Jana Shen

DOI: https://doi.org/10.1021/acschemneuro.4c00212

2024-08-07

Abstract:Opioids are small-molecule agonists of μ-opioid receptor (μOR), while reversal agents such as naloxone are antagonists of μOR. Here, we developed machine learning (ML) models to classify the intrinsic activities of ligands at the human μOR based on the SMILES strings and two-dimensional molecular descriptors. We first manually curated a database of 983 small molecules with measured Emax values at the human μOR. Analysis of the chemical space allowed identification of dominant scaffolds and structurally similar agonists and antagonists. Decision tree models and directed message passing neural networks (MPNNs) were then trained to classify agonistic and antagonistic ligands. The hold-out test AUCs (areas under the receiver operator curves) of the extra-tree (ET) and MPNN models are 91.5 ± 3.9% and 91.8 ± 4.4%, respectively. To overcome the challenge of a small data set, a student-teacher learning method called tritraining with disagreement was tested using an unlabeled data set comprised of 15,816 ligands of human, mouse, and rat μOR, κOR, and δOR. We found that the tritraining scheme was able to increase the hold-out AUC of MPNN models to as high as 95.7%. Our work demonstrates the feasibility of developing ML models to accurately predict the intrinsic activities of μOR ligands, even with limited data. We envisage potential applications of these models in evaluating uncharacterized substances for public safety risks and discovering new therapeutic agents to counteract opioid overdoses.
Treatment of Cardiovascular Disease by Traditional Chinese Medicine Against Pregnane X Receptor

Kuen-Bao Chen,Hsin-Yi Chen,Kuan-Chung Chen,Calvin Yu-Chian Chen

DOI: https://doi.org/10.1155/2014/950191

2014-01-01

BioMed Research International

Abstract:Recently, cardiovascular disease, also known as loop circulatory system diseases or disorders, is one of the serious diseases including heart disease, stroke, atherosclerosis, myocardial infarction, hypertension, hypotension, and thrombosis. Human pregnane X receptor, PXR, plays a crucial role in exogenous and endobiotic metabolism for rabbit, rat, mouse, and human. The PXR activation can protect the blood vessels from damage of hazardous substances. In this study we aim to investigate the potent lead compounds as PXR receptor agonist against cardiovascular disease. To improve drug development of TCM compounds, we aim to investigate the potent lead compounds as PXR agonists from the TCM compounds in TCM Database@Taiwan. The top three TCM compounds, bis(4-hydroxybenzyl) ether mono-β-D-glucopyranoside (BEMG), ixerisoside, and tangshenoside II, have displayed higher potent binding affinities than the positive control, PNU-142721, in the docking simulation. After MD simulations, which can optimize the result of docking simulation and validate the stability of H-bonds between each ligand and PXR protein under dynamic conditions, top TCM compounds, BEMG and tangshenoside II, maintain most of interactions with PXR protein, which keep the ligand binding stable in the binding domain. Hence, we propose BEMG and tangshenoside II as potential lead compounds for further study in drug development process with the PXR protein.
A Machine Learning Model to Predict Drug Transfer Across the Human Placenta Barrier

Juan I. Di Filippo,Mariela Bollini,Claudio N. Cavasotto

DOI: https://doi.org/10.3389/fchem.2021.714678

IF: 5.5

2021-07-20

Frontiers in Chemistry

Abstract:The development of computational models for assessing the transfer of chemicals across the placental membrane would be of the utmost importance in drug discovery campaigns, in order to develop safe therapeutic options. We have developed a low-dimensional machine learning model capable of classifying compounds according to whether they can cross or not the placental barrier. To this aim, we compiled a database of 248 compounds with experimental information about their placental transfer, characterizing each compound with a set of ∼5.4 thousand descriptors, including physicochemical properties and structural features. We evaluated different machine learning classifiers and implemented a genetic algorithm, in a five cross validation scheme, to perform feature selection. The optimization was guided towards models displaying a low number of false positives (molecules that actually cross the placental barrier, but are predicted as not crossing it). A Linear Discriminant Analysis model trained with only four structural features resulted to be robust for this task, exhibiting only one false positive case across all testing folds. This model is expected to be useful in predicting placental drug transfer during pregnancy, and thus could be used as a filter for chemical libraries in virtual screening campaigns.

chemistry, multidisciplinary
Machine Learning-Based Models with High Accuracy and Broad Applicability Domains for Screening PMT/vPvM Substances

Qiming Zhao,Yang Yu,Yuchen Gao,Lilai Shen,Shixuan Cui,Yiyuan Gou,Chunlong Zhang,Shulin Zhuang,Guibin Jiang

DOI: https://doi.org/10.1021/acs.est.2c06155

IF: 11.4

2022-01-01

Environmental Science & Technology

Abstract:Persistent, mobile, and toxic (PMT) substances and very persistent and very mobile (vPvM) substances can transport over long distances from various sources, increasing the public health risk. A rapid and high-throughput screening of PMT/vPvM substances is thus warranted to the risk prevention and mitigation measures. Herein, we construct a machine learning-based screening system integrated with five models for high-throughput classification of PMT/vPvM substances. The models are constructed with 44 971 substances by conventional learning, deep learning, and ensemble learning algorithms, among which, LightGBM and XGBoost outperform other algorithms with metrics exceeding 0.900. Good model interpretability is achieved through the number of free halogen atoms (fr_halogen) and the logarithm of partition coefficient (MolLogP) as the two most critical molecular descriptors representing the persistence and mobility of substances, respectively. Our screening system exhibits a great generalization capability with area under the receiver operating characteristic curve (AUROC) above 0.951 and is successfully applied to the persistent organic pollutants (POPs), prioritized PMT/vPvM substances, and pesticides. The screening system constructed in this study can serve as an efficient and reliable tool for high-throughput risk assessment and the prioritization of managing emerging contaminants.
Initial Development of Automated Machine Learning-Assisted Prediction Tools for Aryl Hydrocarbon Receptor Activators

Paulina Anna Wojtyło,Natalia Łapińska,Lucia Bellagamba,Emidio Camaioni,Aleksander Mendyk,Stefano Giovagnoli

DOI: https://doi.org/10.3390/pharmaceutics16111456

IF: 6.525

2024-11-21

Pharmaceutics

Abstract:Background: The aryl hydrocarbon receptor (AhR) plays a crucial role in immune and metabolic processes. The large molecular diversity of ligands capable of activating AhR makes it impossible to determine the structural features useful for the design of new potent modulators. Thus, in the field of drug discovery, the intricate nature of AhR activation necessitates the development of novel tools to address related challenges. Methods: In this study, quantitative structure–activity relationship (QSAR) models of classification and regression were developed with the objective of identifying the most effective method for predicting AhR activity. The initial dataset was obtained by combining the ChEMBL and WIPO databases which contained 978 molecules with EC50 values. The predictive models were developed using the automated machine learning platform mljar according to a 10-fold cross validation (10-CV) testing procedure. Results: The classification model demonstrated an accuracy value of 0.760 and F1 value of 0.789 for the test set. The root-mean-squared error (RMSE) was 5444, and the coefficient of determination (R2) was 0.208 for the regression model. The Shapley Additive Explanations (SHAP) method was then employed for a deeper comprehension of the impact of the variables on the model's predictions. As a practical application for scientific purposes, the best performing classification model was then used to develop an AhR web application. This application is accessible online and has been implemented in Streamlit. Conclusions: The findings may serve as a foundation in prompting further research into the development of a QSAR model, which could enhance comprehension of the influence of ligand structure on the modulation of AhR activity.

pharmacology & pharmacy
Predicting selective liver X receptor β agonists using multiple machine learning methods.

Yali Li,Ling Wang,Zhihong Liu,Chanjuan Li,Jiake Xu,Qiong Gu,Jun Xu

DOI: https://doi.org/10.1039/c4mb00718b

2015-01-01

Molecular BioSystems

Abstract:Liver X receptor (LXR) alpha and beta are cholesterol sensors; they respond to excess cholesterol and stimulate reverse cholesterol transport. Activating LXRs represents a promising therapeutic option for dyslipidemia. However, activating LXR alpha may cause unwanted lipogenicity. A better anti-dyslipidemia strategy would be to develop selective LXR beta agonists that do not activate LXR alpha. In this paper, a data set of 234 selective and non-selective LXRb agonists was collected from the literature. For the first time, we derived the classification models from the data set to predict selective LXR beta agonists using multiple machine learning methods (naive Bayesian (NB), Recursive Partitioning (RP), Support Vector Machine (SVM), and k-Nearest Neighbors (kNN) methods) with optimized property descriptors and structural fingerprints. The models were optimized from 324 multiple machine learning models, and most of the models showed high predictive abilities (overall predictive accuracies of >80%) for both training and test sets. The top 15 models were evaluated using an external test set of 76 compounds (all containing new scaffolds), and 10 of them displayed overall predictive accuracies exceeding 90%. The top models can be used for the virtual screening of selective LXR beta agonists. The NB models can identify privileged and unprivileged fragments for selective LXR beta agonists, and the fragments can be used to guide the design of new selective LXR beta agonists.
Machine Learned Classification of Ligand Intrinsic Activities at Human mu-Opioid Receptor

Myongin Oh,Maximilian Shen,Ruibin Liu,Lidiya Stavitskaya,Jana Shen

DOI: https://doi.org/10.1101/2024.04.07.588485

2024-06-14

Abstract:Opioids are small-molecule agonists of mu-opioid receptor (muOR), while reversal agents such as naloxone are antagonists of muOR. Here we de- veloped machine learning (ML) models to classify the intrinsic activities of ligands at the human muOR based on the SMILE strings and two-dimensional molecular descriptors. We first manually curated a database of 983 small molecules with measured Emax values at the human μOR. Analysis of the chemical space allowed identification of dominant scaffolds and structurally similar agonists and antagonists. Decision tree models and directed message passing neural networks (MPNNs) were then trained to classify agonistic and antagonistic ligands. The hold-out test AUCs (areas under the receiver operator curves) of the extra-tree (ET) and MPNN models are 91.5\+3.9% and 91.8\+4.4%, respectively. To overcome the challenge of small dataset, a student-teacher learning method called tri-training with disagreement was tested using an unlabeled dataset comprised of 15,816 ligands of human, mouse, or rat muOR, kappaOR, or gammaOR. We found that the tri-training scheme was able to increase the hold-out AUC of MPNN to as high as 95.7%. Our work demonstrates the feasibility of developing ML models to accurately predict the intrinsic activities of μOR ligands, even with limited data. We envisage potential applications of these models in evaluating uncharacterized substances for public safety risks and discovering new therapeutic agents to counteract opioid overdoses.

Bioinformatics
Interpretable machine learning for the identification of estrogen receptor agonists, antagonists, and binders

Geven Piir,Sulev Sild,Uko Maran

DOI: https://doi.org/10.1016/j.chemosphere.2023.140671

IF: 8.8

2024-01-01

Chemosphere

Abstract:An abnormal hormonal activity or exposure to endocrine-disrupting chemicals (EDCs) can cause endocrine system malfunction. Among the many interactions EDCs can affect is the disruption of estrogen signalling, which can lead to adverse health effects such as cancer, osteoporosis, neurodegenerative diseases, cardiovascular disease, insulin resistance, and obesity. Knowing which chemical can act as an EDC is a significant advantage and a practical necessity. New Approach Methodologies (NAM) computational models offer a quick and cost-effective solution for preliminary hazard assessment of chemicals without animal testing. Therefore, a machine learning approach was used to investigate the relationships between estrogen receptor (ER) activity and chemical structure to identify chemicals that can interact with ER. For this purpose, the consolidated in vitro assay data from ToxCast/Tox21 projects was used for developing Random Forest classification models for ER binding, agonists, and antagonists. The overall classification prediction accuracy reaches up to 82%, depending on whether the model predicted agonists, antagonists, or compounds that bind to the active site. Given the imbalance in endocrine disruption data, the derived models are good candidates for deprioritising chemicals and reducing animal testing. The interpretation of theoretical molecular descriptors of the models was consistent with the molecular interactions known in the ligand binding pocket. The estimated class probabilities enabled the analysis of the applicability domain of the developed models and the assessment of the predictions' reliability, followed by the guidelines for interpreting prediction results. The models are openly accessible and useable at QsarDB.org (http://dx.doi.org/10.15152/QDB.259) according to the FAIR (Findable, Accessible, Interoperable, Reusable) principles.

environmental sciences

Machine Learning Based Models for High-Throughput Classification of Human Pregnane X Receptor Activators

In silico prediction of pregnane X receptor activators by machine learning approaches.

In silico identification of human pregnane X receptor activators from molecular descriptors by machine learning approaches

Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique.

Predicting the Androgenicity of Structurally Diverse Compounds from Molecular Structure Using Different Classifiers

Identification and Validation of Novel Human Pregnane X Receptor Activators among Prescribed Drugs Via Ligand-Based Virtual Screening

Predictive Models for Identifying the Binding Activity of Structurally Diverse Chemicals to Human Pregnane X Receptor.

Advances in Search for Pregnane X Receptor

Quantitative Prediction of Human Pregnane X Receptor and Cytochrome P450 3A4 Mediated Drug-Drug Interaction in a Novel Multiple Humanized Mouse Line

Identification of Hpxr Modulators Via Sar-Based Virtual Screening

Prediction of Farnesoid X Receptor Disruptors with Machine Learning Methods.

Rapid Screening of Chemicals with Placental Transfer Risk Using Interpretable Machine Learning

Establishment of hPXR Mediated Reporter Gene Model for UGT1A1 and Its Application

Machine Learned Classification of Ligand Intrinsic Activities at Human μ-Opioid Receptor

Treatment of Cardiovascular Disease by Traditional Chinese Medicine Against Pregnane X Receptor

A Machine Learning Model to Predict Drug Transfer Across the Human Placenta Barrier

Machine Learning-Based Models with High Accuracy and Broad Applicability Domains for Screening PMT/vPvM Substances

Initial Development of Automated Machine Learning-Assisted Prediction Tools for Aryl Hydrocarbon Receptor Activators

Predicting selective liver X receptor β agonists using multiple machine learning methods.

Machine Learned Classification of Ligand Intrinsic Activities at Human mu-Opioid Receptor

Interpretable machine learning for the identification of estrogen receptor agonists, antagonists, and binders